Latest The Michael J. Fox Foundation Stories
Biotech Startup, Collaborator Receive Parkinson's Disease Grant to Study Newly Identified Pathway, Develop Novel Treatments Lexington, Kentucky (PRWEB) December
Fellowship Program Building a Workforce of Parkinson's Disease Care and Research Specialists NEW YORK, Dec. 2, 2014 /PRNewswire-USNewswire/ -- The Michael J.
- Only 28% of Parkinson's patients are currently receiving care from a Parkinson's specialist NEW YORK, Sept.
NEW YORK, Aug. 12, 2014 /PRNewswire-USNewswire/ -- Research projects from five groups active in Parkinson's research comprise the 2014 first half (1H 2014) of The Michael J.
NEW YORK, Aug. 5, 2014 /PRNewswire-USNewswire/ -- Researchers need to know the genetic profiles of their study participants to understand more about how certain mutations manifest disease.
FPRT Bio works closely with academic leaders and research organizations to advance the use of XPro1595 in the treatment of Parkinson’s disease. Dallas, Texas
AFFiRiS AG presents Phase I data on a first-of-its-kind treatment with support from The Michael J.
VIENNA, July 29, 2014 /PRNewswire/ -- What: AFFiRiS AG, Vienna, Austria will present data from a Phase I clinical trial of PD01A, a vaccine approach that aims to slow or
ATLANTA, July 28, 2014 /PRNewswire-USNewswire/ -- RaceTrac announced that its cumulative giving to The Michael J. Fox Foundation for Parkinson's Research has exceeded $1 million.
- A poem in which the author retracts something said in an earlier poem.